ArticlemBio2021

An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines.

Yan Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.